According to the available data from clinical trials and post-marketing surveillance, the side effects of artesunate, an antimalarial medication, can vary in frequency [1].
Common side effects, occurring in more than 10% of patients, include abnormal liver enzymes, decreased hemoglobin levels, headache, dizziness, and vomiting [2].
Less common side effects, occurring in 1% to 10% of patients, include allergic reactions, bronchospasm, hypotension, diarrhea, and renal impairment [3].
Severe side effects, occurring in less than 1% of patients, include anaphylactic reactions, severe hemolysis, and acute kidney injury [4].
The frequency of artesunate side effects may also be influenced by factors such as the population being treated, the dosage and duration of treatment, and the presence of underlying medical conditions [5].
For the most up-to-date and accurate information on artesunate side effects, reference reliable sources such as the Centers for Disease Control and Prevention (CDC) or DrugPatentWatch.com [6], which tracks patent information and approved uses of medications, including artesunate.
Sources:
[1] Centers for Disease Control and Prevention. (2022). Artesunate.
[2] DrugPatentWatch.com. (2022). Artesunate Patent Expiration.
[3] Centers for Disease Control and Prevention. (2022). Malaria Treatment.
[4] World Health Organization. (2022). Artesunate.
[5] Food and Drug Administration. (2022). Artesunate.
[6] DrugPatentWatch.com.